WALTHAM, Mass., May 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD - News) today announced that its financial results for the first quarter of fiscal year 2012 will be released before market open on Tuesday, May 15, 2012, followed the same day by a conference call and live webcast scheduled for 8:00am ET. <\/p>\n
The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the Internet at http:\/\/www.bg-medicine.com<\/a>. <\/p>\n A replay of the call will be available approximately one hour following the end of the call through June 15, 2012. The replay may be accessed by dialing (855) 859-2056 within the U.S. and Canada or (404) 537-3406 from international locations, passcode 72912543. The call will be archived and accessible on the Web site for approximately 30 days. <\/p>\n Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. <\/p>\n About BG Medicine. <\/p>\n BG Medicine, Inc. (Nasdaq:BGMD - News) is a life sciences company focused on the discovery, development and commercialization of novel, biomarker-based cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and contain healthcare costs. The Company's first commercialized product, the BGM Galectin-3TM test for use in patients with heart failure, is available in the United States and Europe. BG Medicine has also developed CardioSCORE, a blood test designed to identify individuals at high risk for near-term major cardiovascular events, such as heart attack and stroke. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http:\/\/www.bg-medicine.com<\/a> and http:\/\/www.galectin-3.com<\/a>. <\/p>\n The BG Medicine Inc. logo is available at http:\/\/www.globenewswire.com\/newsroom\/prs\/?pkgid=10352<\/a> <\/p>\n<\/p>\n Read this article:<\/p>\n BG Medicine Announces First Quarter 2012 Financial Results Release Date and Conference Call Information<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" WALTHAM, Mass., May 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD - News) today announced that its financial results for the first quarter of fiscal year 2012 will be released before market open on Tuesday, May 15, 2012, followed the same day by a conference call and live webcast scheduled for 8:00am ET Continue reading